Tag: press

Hong Kong, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Mango Financial Limited (“Mango” or the "Company") today announced that it has initiated its digital currency strategy by introducing cryptocurrency elements into the Company’s financial operations.

SINGAPORE, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we,” “us” or “our”), today announced its unaudited financial results for the first six months of fiscal year 2025.

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The price of Ethereum (ETH) has shown notable strength over the past 24 hours, trading in the range of $4,619.49 to $4,788.55 (source: CoinMarketCap, August 15, 2025). Against this positive market backdrop, MAGACOIN FINANCE, an Ethereum-based blockchain project, has confirmed the successful close of its $12 million strategic funding round, supported by more than 10,000 verified participants — including a substantial group of early presale contributors.

NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ: SRPT) and certain of its officers.

Transaction Expected to Close in the Coming Days

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years

ROAD TOWN, British Virgin Islands, Aug. 15, 2025 (GLOBE NEWSWIRE) -- LYNO AI has entered a pivotal stage in its Early Bird presale, offering tokens at $0.050 each before the price increases to $0.055 in the second phase. This initial offering has already seen strong participation, with nearly 270,000 tokens sold from the total planned issuance of 16 million, underscoring active market engagement as the project progresses toward its next milestone.

BOSTON, MASSACHUSETTS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a pioneering clinical stage biotechnology company at the forefront of oxygen therapeutics, is proud to announce a major scientific milestone: the publication of Body Oxygen Homeostasis and Mitochondrial Function from Animal Models to Clinical Applications by Prof. Avraham Mayevsky, a key advisor to Bioxytran. This groundbreaking work dives deep into the science of oxygen regulation and mitochondrial health – revealing transformative insights that could redefine treatment for stroke, Alzheimer’s, and other critical conditions.

https://link.springer.com/book/10.1007/978-3-031-94113-9